A Relative Bioavailability and Food-Effect Study of the Fixed Dose Combination of GSK3640254 and Dolutegravir (DTG) in Healthy Participants

NCT04857892 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: GSK3640254
DRUG: DTG
DRUG: GSK3640254/DTG

Sponsor

ViiV Healthcare